» Articles » PMID: 25746630

Macrolide Therapy Suppresses Key Features of Experimental Steroid-sensitive and Steroid-insensitive Asthma

Overview
Journal Thorax
Date 2015 Mar 10
PMID 25746630
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Steroid-insensitive endotypes of asthma are an important clinical problem and effective therapies are required. They are associated with bacterial infection and non-eosinophilic inflammatory responses in the asthmatic lung. Macrolide therapy is effective in steroid-insensitive endotypes, such as non-eosinophilic asthma. However, whether the effects of macrolides are due to antimicrobial or anti-inflammatory mechanisms is not known.

Objective: To determine and assess the efficacy of macrolide (ie, clarithromycin) and non-macrolide (ie, amoxicillin) antibiotic treatments in experimental models of infection-induced, severe, steroid-insensitive neutrophilic allergic airways disease (SSIAAD), compared with steroid-sensitive AAD and to delineate the antimicrobial and anti-inflammatory effects of macrolide therapy.

Methods: We developed and used novel mouse models of Chlamydia and Haemophilus lung infection-induced SSIAAD. We used these models to investigate the effects of clarithromycin and amoxicillin treatment on immune responses and airways hyper-responsiveness (AHR) in Ova-induced, T helper lymphocyte (Th) 2 -associated steroid-sensitive AAD and infection-induced Th1/Th17-associated SSIAAD compared with dexamethasone treatment.

Results: Clarithromycin and amoxicillin had similar antimicrobial effects on infection. Amoxicillin did attenuate some features, but did not broadly suppress either form of AAD. It did restore steroid sensitivity in SSIAAD by reducing infection. In contrast, clarithromycin alone widely suppressed inflammation and AHR in both steroid-sensitive AAD and SSIAAD. This occurred through reductions in Th2 responses that drive steroid-sensitive eosinophilic AAD and tumour necrosis factor α and interleukin 17 responses that induce SSIAAD.

Conclusions: Macrolides have broad anti-inflammatory effects in AAD that are likely independent of their antimicrobial effects. The specific responses that are suppressed are dependent upon the responses that dominate during AAD.

Citing Articles

Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.

Liu G, Hsu A, Geirnaert S, Cong C, Nair P, Shen S Mol Ther. 2025; 33(3):917-932.

PMID: 39838644 PMC: 11897773. DOI: 10.1016/j.ymthe.2025.01.032.


The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation.

Wang Z, Li H, Maskey A, Srivastava K, Liu C, Yang N J Inflamm Res. 2024; 17:2547-2561.

PMID: 38686360 PMC: 11057679. DOI: 10.2147/JIR.S433430.


Characterization and inhibition of inflammasome responses in severe and non-severe asthma.

Horvat J, Kim R, Weaver N, Augood C, Brown A, Donovan C Respir Res. 2023; 24(1):303.

PMID: 38044426 PMC: 10694870. DOI: 10.1186/s12931-023-02603-2.


4-Octyl Itaconate Alleviates Airway Eosinophilic Inflammation by Suppressing Chemokines and Eosinophil Development.

Yin M, Wadhwa R, Marshall J, Gillis C, Kim R, Dua K J Immunol. 2023; 212(1):13-23.

PMID: 37991425 PMC: 7617081. DOI: 10.4049/jimmunol.2300155.


TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase.

Liu G, Haw T, Starkey M, Philp A, Pavlidis S, Nalkurthi C Nat Commun. 2023; 14(1):7349.

PMID: 37963864 PMC: 10646046. DOI: 10.1038/s41467-023-42913-z.